Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan Levin

Showing results (81-90 of 148) with videos related to

Pageof 15
Sort By:
Bulletin of the World Health Organization|July 20, 2007
Operational effectiveness of single-dose nevirapine in preventing mother-to-child transmission of HIVMark Colvin, Mickey Chopra, Tanya Doherty, et al.
Plos One|January 1, 2019
Discontinuing cotrimoxazole preventive therapy in HIV-infected adults who are stable on antiretroviral treatment in Uganda (COSTOP): A randomised placebo controlled trialZacchaeus Anywaine, Jonathan Levin, Ronnie Kasirye, et al.
AIDS (London, England)|January 29, 2014
Home-based versus clinic-based care for patients starting antiretroviral therapy with low CD4⁺ cell counts: findings from a cluster-randomized trialSusannah L Woodd, Heiner Grosskurth, Jonathan Levin, et al.
Plos One|June 17, 2011
Prevalence and incidence of HIV in a rural community-based HIV vaccine preparedness cohort in Masaka, UgandaEugene Ruzagira, Symon Wandiembe, Andrew Abaasa, et al.
Tropical Medicine & International Health : TM & IH|October 20, 2010
Barriers to starting ART and how they can be overcome: individual and operational factors associated with early and late start of treatmentRosalind Parkes-Ratanshi, Leonard Bufumbo, Barbara Nyanzi-Wakholi, et al.
AIDS (London, England)|January 26, 2017
Effect of antiretroviral therapy on malaria incidence in HIV-infected Ugandan adultsRonnie P Kasirye, Heiner Grosskurth, Paula Munderi, et al.
AIDS (London, England)|November 13, 2015
Incidence of malaria by cotrimoxazole use in HIV-infected Ugandan adults on antiretroviral therapy: a randomised, placebo-controlled studyRonnie P Kasirye, Kathy Baisley, Paula Munderi, et al.
AIDS Research and Therapy|May 10, 2017
COHORT PROFILE: The Complications of Long-Term Antiretroviral Therapy study in Uganda (CoLTART), a prospective clinical cohortBilly Nsubuga Mayanja, Ivan Kasamba, Jonathan Levin, et al.
Tropical Medicine & International Health : TM & IH|March 12, 2011
Decreasing trends of bacteraemia among HIV-infected Ugandan adults: incidence, aetiology, clinical outcomes and effect of antiretroviral therapy in a semi-urban setting (2000-2008)Stella Zawedde Muyanja, Natasha Larke, Diana Rutebarika, et al.
International Journal of Epidemiology|April 8, 2011
In utero and intra-partum HIV-1 transmission and acute HIV-1 infection during pregnancy: using the BED capture enzyme-immunoassay as a surrogate marker for acute infectionEdmore T Marinda, Lawrence H Moulton, Jean H Humphrey, et al.
Pageof 15

Showing results (81-90 of 148) with videos related to

Sort By:
Pageof 15
Bulletin of the World Health Organization|July 20, 2007
Operational effectiveness of single-dose nevirapine in preventing mother-to-child transmission of HIVMark Colvin, Mickey Chopra, Tanya Doherty, et al.
Plos One|January 1, 2019
Discontinuing cotrimoxazole preventive therapy in HIV-infected adults who are stable on antiretroviral treatment in Uganda (COSTOP): A randomised placebo controlled trialZacchaeus Anywaine, Jonathan Levin, Ronnie Kasirye, et al.
AIDS (London, England)|January 29, 2014
Home-based versus clinic-based care for patients starting antiretroviral therapy with low CD4⁺ cell counts: findings from a cluster-randomized trialSusannah L Woodd, Heiner Grosskurth, Jonathan Levin, et al.
Plos One|June 17, 2011
Prevalence and incidence of HIV in a rural community-based HIV vaccine preparedness cohort in Masaka, UgandaEugene Ruzagira, Symon Wandiembe, Andrew Abaasa, et al.
Tropical Medicine & International Health : TM & IH|October 20, 2010
Barriers to starting ART and how they can be overcome: individual and operational factors associated with early and late start of treatmentRosalind Parkes-Ratanshi, Leonard Bufumbo, Barbara Nyanzi-Wakholi, et al.
AIDS (London, England)|January 26, 2017
Effect of antiretroviral therapy on malaria incidence in HIV-infected Ugandan adultsRonnie P Kasirye, Heiner Grosskurth, Paula Munderi, et al.
AIDS (London, England)|November 13, 2015
Incidence of malaria by cotrimoxazole use in HIV-infected Ugandan adults on antiretroviral therapy: a randomised, placebo-controlled studyRonnie P Kasirye, Kathy Baisley, Paula Munderi, et al.
AIDS Research and Therapy|May 10, 2017
COHORT PROFILE: The Complications of Long-Term Antiretroviral Therapy study in Uganda (CoLTART), a prospective clinical cohortBilly Nsubuga Mayanja, Ivan Kasamba, Jonathan Levin, et al.
Tropical Medicine & International Health : TM & IH|March 12, 2011
Decreasing trends of bacteraemia among HIV-infected Ugandan adults: incidence, aetiology, clinical outcomes and effect of antiretroviral therapy in a semi-urban setting (2000-2008)Stella Zawedde Muyanja, Natasha Larke, Diana Rutebarika, et al.
International Journal of Epidemiology|April 8, 2011
In utero and intra-partum HIV-1 transmission and acute HIV-1 infection during pregnancy: using the BED capture enzyme-immunoassay as a surrogate marker for acute infectionEdmore T Marinda, Lawrence H Moulton, Jean H Humphrey, et al.
Pageof 15